Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial†

Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study

(2013) M de Camargo Cancela et al.   BRITISH JOURNAL OF CANCER

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

(2013) C. Parker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer

(2012) Bo Dai et al.   BJU INTERNATIONAL

Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment

(2012) Eduardo García-Cruz et al.   BJU INTERNATIONAL

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

(2012) Karim Fizazi et al.   LANCET ONCOLOGY

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

(2012) Howard I. Scher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

(2012) Charles J. Ryan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prostate cancer in the elderly

(2011) Emil Scosyrev et al.   CANCER

Abiraterone and Increased Survival in Metastatic Prostate Cancer

(2011) Johann S. de Bono et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

(2010) Johann Sebastian de Bono et al.   LANCET

Management of metastatic prostate cancer: the crucial role of geriatric assessment

(2008) Jean-Pierre Droz et al.   BJU INTERNATIONAL

Docetaxel-Based Chemotherapy in Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer

(2008) Antoine Italiano et al.   EUROPEAN UROLOGY

Leydig cell aging and the mechanisms of reduced testosterone synthesis

(2008) Andrew S. Midzak et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY